Carl Icahn

FDA advisory panel narrowly endorses Grail's Galleri multi-cancer blood test

An FDA advisory panel voted 6-4 to affirm the effectiveness of Grail's Galleri screening, clearing a hurdle ahead of the agency's final decision.